FDA & Regulatory

Technology and Regulatory Affairs Department

AdvaMed's Technology and Regulatory Affairs (T&R) department works to ensure that patients have timely access to needed medical technologies. Our goal is to ensure that regulatory processes, especially those involving the Food and Drug Administration (FDA), are reasonable and predictable and result in science-based decisions. We work with members to develop pre-market approval policies that speed patient access to new technologies, ensure reasonable post-market and inspection programs, develop a legislative agenda, and to coordinate on international regulatory efforts.

Inside this section...

	AdvaMed Announces
	AdvaMed’s Interventional Cardiology Working Group Plays Important Role in Drug-Eluting Stent Issues
	Industry's Input Included in Report from HHS Secretary's Advisory Committee on Genetics, Health and Society
	FDA Forms Public-Private Partnership to Streamline Clinical Trials